The program will be divided into three phases. The first phase will show proof-of-concept studies for safety and efficacy in in vitro studies. The second phase seeks to validate these findings with either fungal or bacterial infections in animal models, while the final phase aims to increase survival in animals exposed to both fungal and bacterial pathogens simultaneously.
Correct me if I'm wrong, but it sounds like this is just an idea and they still are looking for basic proof of concept as step one.
Good to see this issue is making someone's radar but I'm a little eh on the proposed solution.
Correct me if I'm wrong, but it sounds like this is just an idea and they still are looking for basic proof of concept as step one.
Good to see this issue is making someone's radar but I'm a little eh on the proposed solution.